{
    "Trade/Device Name(s)": [
        "Verigene\u00ae System",
        "Verigene HC Nucleic Acid Test",
        "Verigene F5 Nucleic Acid Test",
        "Verigene F2 Nucleic Acid Test",
        "Verigene MTHFR Nucleic Acid Test",
        "Verigene F5 / F2 / MTHFR Nucleic Acid Test",
        "Verigene F5 / F2 Nucleic Acid Test",
        "Verigene F2 Nucleic Acid Test",
        "Verigene F5 Nucleic Acid Test",
        "Verigene MTHFR Nucleic Acid Test"
    ],
    "Submitter Information": "Nanosphere, Inc.",
    "510(k) Number": "K070597",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033734",
        "K033607",
        "K033612"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NPQ",
        "NPR",
        "OMM",
        "NSU"
    ],
    "Summary Letter Date": "October 5, 2007",
    "Summary Letter Received Date": "October 9, 2007",
    "Submission Date": "October 5, 2007",
    "Regulation Number(s)": [
        "21 CFR 864.7280",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Factor V Leiden DNA mutation detection systems",
        "Instrumentation for clinical multiplex test systems"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Factor V (F5, Factor V Leiden)",
        "Factor II (F2, prothrombin G20210A mutation)",
        "5,10 methylenetetrahydrofolate reductase (MTHFR, C677T mutation)"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Genomic DNA"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Verigene\u00ae System",
        "Verigene Processor",
        "Verigene Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Gold nanoparticle probe technology",
        "Genotyping via hybridization",
        "Nucleic acid analysis"
    ],
    "Methodologies": [
        "DNA hybridization",
        "SNP genotyping",
        "Multiplex molecular diagnostics"
    ],
    "Submission Type(s)": [
        "System",
        "Test",
        "Assay",
        "Platform",
        "Analyzer",
        "Cartridge",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Nanosphere Verigene System and associated nucleic acid genotyping assays for thrombophilia-associated genetic mutations using gold nanoparticle probe technology.",
    "Indications for Use Summary": "Aids in diagnosing patients with suspected thrombophilia by detecting specific genetic mutations (Factor V Leiden, Factor II G20210A, MTHFR C677T) from whole blood-derived DNA, intended for use on the Verigene System.",
    "fda_folder": "Clinical Chemistry"
}